European Heart Journal Supplements

Papers
(The H4-Index of European Heart Journal Supplements is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies69
Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review44
Long COVID: long-term effects?35
What do we do about atrial high rate episodes?30
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation25
Left ventricular unloading and the role of ECpella24
Atrial fibrillation in low- and middle-income countries: a narrative review23
Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites23
Lipoprotein(a) and PCSK9 inhibition: clinical evidence21
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal19
Coagulopathy and COVID-1919
Atrial fibrillation: villain or bystander in vascular brain injury18
Concomitant diabetes with atrial fibrillation and anticoagulation management considerations17
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction16
Infective endocarditis and neurologic events: indications and timing for surgical interventions16
0.057399034500122